Atypical bacteria and macrolides in asthma

Allergy, Asthma and Clinical Immunology

Volumn 4, Issue 3, 2008, Pages 111-116

  Xepapadaki, Paraskevi ^a   Koutsoumpari, Ioanna ^a   Papaevagelou, Vasiliki ^a   Karagianni, Christina ^a   Papadopoulos, Nikolaos G ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b Allergy Research Center   (Greece)

Author keywords

Asthma; Chlamydophila pneumoniae; Mycoplasma pneumoniae

Indexed keywords

CLARITHROMYCIN; KETOLIDE; MACROLIDE; PLACEBO; ROXITHROMYCIN; TELITHROMYCIN;

ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; ASTHMA; BACTERIAL INFECTION; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; LUNG FUNCTION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; RESPIRATORY TRACT DISEASE; TREATMENT DURATION; WHEEZING;

EID: 51349114143     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2008.00012     Document Type: Article

References (68)

1. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43.
2. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007;62:102-12.
3. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur Respir J 2007;29:179-84.
4. Xepapadaki P, Papadopoulos NG. Viral infections and allergies. Immunobiology 2007;212:453-9.
5. Nisar N, Guleria R, Kumar S, et al. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007;83:100-4.
6. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986;315:161-8.
7. Harris JA, Kolokathis A, Campbell M, et al. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children. Pediatr Infect Dis J 1998;17:865-71.
8. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis 1996;2:307-19.
9. Hammerschlag MR. The intracellular life of chlamydiae. Semin Pediatr Infect Dis 2002;13:239-48.
10. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004;24:17141.
11. Martin RJ. Infections and asthma. Clin Chest Med 2006;27:87-98, vi.
12. Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 2005;14:773-8.
13. Tsolia MN, Psarras S, Bossios A, et al. Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections. Clin Infect Dis 2004;39:681-6.
14. von Hertzen L, Isoaho R, Leinonen M, et al. Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease. Int J Epidemiol 1996;25:658-64.
15. Hardy RD, Jafri HS, Olsen K, et al. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect Immun 2002;70:649-54.
16. Principi N, Esposito S. Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients. Curr Opin Infect Dis 2002;15:295-300.
17. Katz B, Waites K. Emerging intracellular bacterial infections. Clin Lab Med 2004;24:627-49, vi.
18. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:1225-9.
19. Allegra L, Blasi F, Centanni S, et al. Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection. Eur Respir J 1994;7:2165-8.
20. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991;266:225-30.
21. Hahn DL, Golubjatnikov R. Asthma and chlamydial infection: a case series. J Fam Pract 1994;38:589-95.
22. Biscardi S, Lorrot M, Marc E, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004;38:1341-6.
23. Thumerelle C, Deschildre A, Bouquillon C, et al. Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France). Pediatr Pulmonol 2003;35:7542.
24. Korppi M, Paldanius M, Hyvarinen A, et al. Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children. Respirology 2004;9:255-9.
25. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:595-601.
26. Tuuminen T, Edelstein I, Punin A, et al. Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma. Clin Microbiol Infect 2004;10: 345-8.
27. Gern JE, Lemanske RF Jr. Infectious triggers of pediatric asthma. Pediatr Clin North Am 2003;50:555-75, vi.
28. Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis 1997;16:388-91.
29. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001;32:1281-9.
30. Betsou F, Sueur JM, Orfila J. Anti-Chlamydia pneumoniae heat shock protein 10 antibodies in asthmatic adults. FEMS Immunol Med Microbiol 2003;35:107-11.
31. Cook PJ, Davies P, Tunnicliffe W, et al. Chlamydia pneumoniae and asthma. Thorax 1998;53:254-9.
32. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J 1998;11:345-9.
33. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727-32.
34. Esposito S, Droghetti R, Bosis S, et al. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol 2002;34:122-7.
35. Meloni F, Paschetto E, Mangiarotti P, et al. Acute Chlamydia pneumoniae and Mycoplasma. pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations. J Chemother 2004;16:70-6.
36. Miyashita N, Kubota Y, Nakajima M, et al. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 1998;80:405-9.
37. Lieberman D, Printz S, Ben-Yaakov M, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 2003;167:406-10.
38. Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763.
39. Esposito S, Blasi F, Arosio C, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000;16:1142-6.
40. Freymuth F, Vabret A, Brouard J, et al. Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999;13:131-9.
41. ten Brinke A, van Dissel JT, Sterk PJ, et al. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 2001;107:449-54.
42. Pasternack R, Huhtala H, Karjalainen J. Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis. J Allergy Clin Immunol 2005;116:1123-8.
43. Schmidt SM, Muller CE, Wiersbitzky SK. Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children. Pediatr Allergy Immunol 2005;16:137-44.
44. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005;172:1078-89.
45. Black PN, Scicchitano R, Jenkins CR, et al. Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 2000;15:254-9.
46. Falck G, Gnarpe J, Hansson LO, et al. Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome. Chest 2002;122:1587-93.
47. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998;158:998-1001.
48. Huittinen T, Hahn D, Anttila T, et al. Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma. Eur Respir J 2001;17:1078-82.
49. Chu HW, Honour JM, Rawlinson CA, et al. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003;71:1520-6.
50. Chu HW, Rino JG, Wexler RB, et al. Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005;289:L125-33.
51. Ferrari M, Poli A, Olivieri M, et al. Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults. Infection 2002;30:203-7.
52. Kaplan MA, Goldin M. The use of triacetyloleandomycin in chronic infectious asthma. Antibiot Annu 1958;6:273-6.
53. Hirschmann JV. Antibiotics for common respiratory tract infections in adults. Arch Intern Med 2002;162:256-64.
54. Blasi F, Johnston SL. The role of antibiotics in asthma. Int J Antimicrob Agents 2007;29:485-93.
55. Shinkai M, Rubin BK. Macrolides and airway inflammation in children. Paediatr Respir Rev 2005;6:227-35.
56. Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004;125:52S-60S; quiz S-1S.
57. Shinkai M, Foster GH, Rubin BK. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006;290:L75-85.
58. Hahn DL. Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial. J Fam Pract 1995;41:345-51.
59. Kostadima E, Tsiodras S, Alexopoulos EL et al. Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma. Eur Respir J 2004;23:714-7.
60. Fost DA, Leung DY, Martin RJ, et al. Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy. J Allergy Clin Immunol. 1999;103:1031-5.
61. Amayasu H, Yoshida S, Ebana S, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000;84:594-8.
62. Spahn JD, Fost DA, Covar R, et al. Clarithromycin potentiates glucocorticoid responsiveness in patients with asthma: results of a pilot study. Ann Allergy Asthma Immunol 2001;87:501-5.
63. Black PN, Blasi F, Jenkins CR, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001;164: 536-41.
64. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002;121:1782-8.
65. Richeldi L, Ferrara G, Fabbri LM, et al. Macrolides for chronic asthma. Cochrane Database Syst Rev 2005;4:CD002997.
66. Johnston SL, Blasi F, Black PN, et al. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med 2006;354:1589-600.
67. Little FF. Treating acute asthma with antibiotics - not quite yet. N Engl J Med 2006;354:1632-4.
68. Esposito S, Blasi F, Bosis F, et al. Efficacy of clarithromycin for the treatment of acute episodes of bronchospasm in children with a history of recurrent wheezing. 22nd annual meeting of European Society for Pediatric Infectious Diseases (ESPID). Tampere, Finland, 2004.